Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Revenue

Orient Pharma had revenue of 619.84M TWD in the half year ending December 31, 2024, with 185.94% growth. This brings the company's revenue in the last twelve months to 1.26B, up 29.25% year-over-year. In the year 2024, Orient Pharma had annual revenue of 1.22B with 37.41% growth.

• Revenue (ttm): 1.26B
• Revenue Growth: +29.25%
• P/S Ratio: 6.35
• Revenue / Employee: 7.31M
• Employees: 173
• Market Cap: 8.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.22B	332.90M	37.41%
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%
Dec 31, 2020	412.01M	58.47M	16.54%